Virtu Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-9,863
| Closed | -$5.55M | – | 2138 |
|
|
2025
Q3 | $5.55M | Buy |
9,863
+6,688
| +211% | +$3.78M | 0.31% | 48 |
|
|
2025
Q2 | $1.67M | Sell |
3,175
-1,462
| -32% | -$816K | 0.09% | 209 |
|
|
2025
Q1 | $2.94M | Buy |
4,637
+343
| +8% | +$236K | 0.16% | 76 |
|
|
2024
Q4 | $3.06M | Sell |
4,294
-1,760
| -29% | -$1.48M | 0.16% | 104 |
|
|
2024
Q3 | $6.36M | Buy |
+6,054
| New | +$6.74M | 0.35% | 37 |
|
|
2023
Q3 | – | Sell |
-9,431
| Closed | -$6.78M | – | 1784 |
|
|
2023
Q2 | $6.78M | Buy |
+9,431
| New | +$7.27M | 0.52% | 23 |
|
|
2023
Q1 | – | Sell |
-315
| Closed | -$227K | – | 1998 |
|
|
2022
Q4 | $227K | Buy |
+315
| New | +$232K | 0.03% | 639 |
|
|
2022
Q3 | – | Sell |
-11,126
| Closed | -$6.58M | – | 2145 |
|
|
2022
Q2 | $6.58M | Buy |
+11,126
| New | +$7.23M | 0.56% | 22 |
|
|
2021
Q4 | – | Sell |
-1,500
| Closed | -$908K | – | 2099 |
|
|
2021
Q3 | $908K | Buy |
+1,500
| New | +$931K | 0.08% | 260 |
|
|
2021
Q2 | – | Sell |
-483
| Closed | -$229K | – | 1983 |
|
|
2021
Q1 | $229K | Buy |
+483
| New | +$235K | 0.02% | 997 |
|
|
2020
Q4 | – | Sell |
-902
| Closed | -$505K | – | 1731 |
|
|
2020
Q3 | $505K | Buy |
+902
| New | +$547K | 0.09% | 283 |
|
|
2019
Q4 | – | Sell |
-2,055
| Closed | -$570K | – | 1774 |
|
|
2019
Q3 | $570K | Sell |
2,055
-4,648
| -69% | -$1.38M | 0.04% | 466 |
|
|
2019
Q2 | $2.1M | Buy |
6,703
+5,767
| +616% | +$1.92M | 0.12% | 134 |
|
|
2019
Q1 | $384K | Buy |
+936
| New | +$385K | 0.02% | 685 |
|
|
2018
Q4 | – | Sell |
-583
| Closed | -$236K | – | 1913 |
|
|
2018
Q3 | $236K | Buy |
+583
| New | +$222K | 0.01% | 987 |
|
|
2018
Q1 | – | Sell |
-9,233
| Closed | -$3.47M | – | 2480 |
|
|
2017
Q4 | $3.47M | Buy |
9,233
+6,968
| +308% | +$2.82M | 0.18% | 74 |
|
|
2017
Q3 | $1.01M | Buy |
+2,265
| New | +$1.08M | 0.05% | 445 |
|
|
2016
Q4 | – | Sell |
-1,317
| Closed | -$529K | – | 539 |
|
|
2016
Q3 | $529K | Buy |
+1,317
| New | +$528K | 0.09% | 187 |
|
|
2016
Q1 | – | Sell |
-1,677
| Closed | -$910K | – | 490 |
|
|
2015
Q4 | $910K | Buy |
+1,677
| New | +$909K | 0.13% | 158 |
|
|
2015
Q3 | – | Sell |
-1,957
| Closed | -$998K | – | 382 |
|
|
2015
Q2 | $998K | Buy |
+1,957
| New | +$955K | 0.09% | 146 |
|
|
2015
Q1 | – | Sell |
-1,033
| Closed | -$424K | – | 367 |
|
|
2014
Q4 | $424K | Sell |
1,033
-383
| -27% | -$151K | 0.05% | 211 |
|
|
2014
Q3 | $510K | Buy |
+1,416
| New | +$475K | 0.05% | 186 |
|
|
2014
Q1 | – | Sell |
-1,111
| Closed | -$306K | – | 431 |
|
|
2013
Q4 | $306K | Buy |
+1,111
| New | +$320K | 0.03% | 213 |
|
Other funds holding REGN
Virtu Financial's REGN Position: Q4 2025 in Review
Virtu Financial sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 9,863 shares — an estimated $5.55M sold.
Virtu Financial first reported a position in REGN in Q4 2013 and held it in 23 quarters. The position peaked at $6.78M in Q2 2023. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.
- Virtu Financial reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Virtu Financial sold 9,863 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $5.55M.
- Virtu Financial first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 23 quarters.
- Virtu Financial's Regeneron Pharmaceuticals position peaked at $6.78M in Q2 2023.
- 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.
Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.